← Evidence map

ArticleLeukemia2005

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.

G Schuch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2005

…

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this papercites it

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. | OpenQuestion